← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Aciont, Inc.
Salt Lake City, UT
$4,853,340
Total funding
5
Grants
Funding over time
peak $1.3M · FY2009–15$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$4,853,340 · 5
By mechanism
R44$4,205,637 · 1
R43$647,703 · 4
Investigators at Aciont, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Non-Invasive Drug Delivery to Treat Severe Uveitis$1,086,144
R44 · FY2010 · EY
Non-Invasive Drug Delivery to Treat Severe Uveitis$1,084,901
R44 · FY2009 · EY
Non-Invasive Treatment for Uveitis$1,073,868
R44 · FY2013 · EY
Non-Invasive Treatment for Uveitis$955,724
R44 · FY2014 · EY
Novel Method for the Ocular Iontophoretic Delivery of Avastin and Lucentis$214,000
R43 · FY2010 · EY
Non-Invasive Blood Phenylalanine Monitor$159,509
R43 · FY2002 · DK
Improved non-invasive blood glucose monitoring device$140,992
R43 · FY2002 · DK
Non-Invasive Drug Delivery to Treat Posterior Uveitis$133,202
R43 · FY2004 · EY
Non-Invasive Treatment for Uveitis$5,000
R44 · FY2015 · EY